NMDA Receptor Antagonists for the Treatment of Neuropsychiatric Disorders.

Provided are pharmaceutical compositions and methods of treatment or prophylaxis of certain neuropsychiatric conditions, in particular mood disorders. The compounds are of the general Formula I-V as described herein.

Patents:
MX 2,010,012,186 [MORE INFO]

Inventor(s): TRAYNELIS STEPHEN F [US]; DINGLEDINE RAYMOND J

Type of Offer: Licensing